2019 / 02

Next Paper
DOI: 10.24075/brsmu.2019.028

OPINION

Adenosine-to-inosine RNA editing may be implicated in human pathogenesis

Kliuchnikova AA1, Moshkovskii SA2
About authors

1 Orekhovich Research Institute of Biomedical Chemistry, Moscow, Russia

2 Pirogov Russian National Research Medical University, Moscow, Russia

Correspondence should be addressed: Anna A. Kliuchnikova
Pogodinskaya 10, bld. 8, Moscow, 119121; moc.liamg@avokinhcuilk.a

About paper

Funding: the work was performed within The Programme for fundamental scientific research of state science academies for 2013–2020.

Author contribution: both authors have contributed equally to manuscript writing.

Received: 2018-08-13 Accepted: 2019-04-06 Published online: 2019-04-17
|
  1. Tan MH, Li Q, Shanmugam R, Piskol R, Kohler J, Young AN, et al. Dynamic landscape and regulation of RNA editing in mammals. Nature. 2017; (550): 249–54.
  2. Basilio C, Wahba AJ, Lengyel P, Speyer JF, Ochoa S. Synthetic polynucleotides and the amino acid code. V Proc Natl Acad Sci USA. 1962; (48): 613–6.
  3. Liscovitch-Brauer N, Alon S, Porath HT, Elstein B, Unger R, Ziv T, et al. Trade-off between Transcriptome Plasticity and Genome Evolution in Cephalopods. Cell. 2017; (169): 191–202.e11.
  4. Gallo A, Vukic D, Michalík D, O’Connell MA, Keegan LP. ADAR RNA editing in human disease; more to it than meets the I. Hum Genet. 2017; (136): 1265–78.
  5. Young PE, Kum Jew S, Buckland ME, Pamphlett R, Suter CM. Epigenetic differences between monozygotic twins discordant for amyotrophic lateral sclerosis (ALS) provide clues to disease pathogenesis. PLoS One. 2017; (12): e0182638.
  6. Taylor DR, Puig M, Darnell MER, Mihalik K, Feinstone SM. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J Virol. 2005; (79): 6291–8.
  7. Suspène R, Petit V, Puyraimond-Zemmour D, Aynaud MM, Henry M, Guétard D, et al. Double-stranded RNA adenosine deaminase ADAR-1-induced hypermutated genomes among inactivated seasonal influenza and live attenuated measles virus vaccines. J Virol. 2011; (85): 2458–62.
  8. John L, Samuel CE. Induction of stress granules by interferon and down-regulation by the cellular RNA adenosine deaminase ADAR1. Virology. 2014; (454–455): 299–310.
  9. Crow YJ. Aicardi-Goutières syndrome. Handb Clin Neurol. 2013; (113): 1629–35.
  10. Tomczak K, Czerwińska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. Contemp Oncol (Poznan, Poland). 2015; (19): A68–77.
  11. Peng X, Xu X, Wang Y, Hawke DH, Yu S, Han L, et al. A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer. Cancer Cell. 2018; (33): 817–828.e7.
  12. Galeano F, Rossetti C, Tomaselli S, Cifaldi L, Lezzerini M, Pezzullo M, et al. ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis. Oncogene. 2013; (32): 998–1009.
  13. Chen L, Li Y, Lin CH, Chan THM, Chow RKK, Song Y, et al. Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med. 2013; (19): 209–16.
  14. Han L, Diao L, Yu S, Xu X, Li J, Zhang R, et al. The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers. Cancer Cell. 2015; (28): 515–28.
  15. Xu X, Wang Y, Liang H. The role of A-to-I RNA editing in cancer development. Curr Opin Genet Dev. 2018; (48): 51–6.